CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR)

Federica Sangiuolo, Maria Lucia Scaldaferri, Antonio Filareto, Paola Spitalieri, Lorenzo Guerra, Maria Favia, Rosa Caroppo, Ruggiero Mango, Emanuela Bruscia, Dieter C. Gruenert, Valeria Casavola, Massimo De Felici, Giuseppe Novelli

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Different gene targeting approaches have been developed to modify endogenous genomic DNA in both human and mouse cells. Briefly, the process involves the targeting of a specific mutation in situ leading to the gene correction and the restoration of a normal gene function. Most of these protocols with therapeutic potential are oligonucleotide based, and rely on endogenous enzymatic pathways. One gene targeting approach, "Small Fragment Homologous Replacement (SFHR)", has been found to be effective in modifying genomic DNA. This approach uses small DNA fragments (SDF) to target specific genomic loci and induce sequence and subsequent phenotypic alterations. This study shows that SFHR can stably introduce a 3-bp deletion (deltaF508, the most frequent cystic fibrosis (CF) mutation) into the Cftr (CF Transmembrane Conductance Regulator) locus in the mouse embryonic stem (ES) cell genome. After transfection of deltaF508-SDF into murine ES cells, SFHR-mediated modification was evaluated at the molecular levels on DNA and mRNA obtained from transfected ES cells. About 12% of transcript corresponding to deleted allele was detected, while 60% of the electroporated cells completely last any measurable CFTR-dependent chloride efflux The data indicate that the SFHR technique can be used to effectively target and modify genomic sequences in ES cells. Once the SFHR-modified ES cells differentiate into different cell lineages they can be useful for elucidating tissue-specific gene function and for the development of transplantation-based cellular and therapeutic protocols.

Original languageEnglish
Pages (from-to)2989-2999
Number of pages11
JournalFrontiers in Bioscience
Volume13
Issue number8
DOIs
Publication statusPublished - 2008

Fingerprint

Gene Targeting
Stem cells
Embryonic Stem Cells
Genes
DNA
Cystic Fibrosis Transmembrane Conductance Regulator
Mutation
Cell Lineage
Cystic Fibrosis
Oligonucleotides
Transfection
Chlorides
Transplantation
Restoration
Alleles
Mouse Embryonic Stem Cells
Genome
Messenger RNA
Tissue
Therapeutics

Keywords

  • CFTR
  • Embryonic stem cells
  • Homologous replacement
  • Real-time PCR
  • SFHR

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology
  • Medicine(all)

Cite this

Sangiuolo, F., Scaldaferri, M. L., Filareto, A., Spitalieri, P., Guerra, L., Favia, M., ... Novelli, G. (2008). CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR). Frontiers in Bioscience, 13(8), 2989-2999. https://doi.org/10.2741/2904

CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR). / Sangiuolo, Federica; Scaldaferri, Maria Lucia; Filareto, Antonio; Spitalieri, Paola; Guerra, Lorenzo; Favia, Maria; Caroppo, Rosa; Mango, Ruggiero; Bruscia, Emanuela; Gruenert, Dieter C.; Casavola, Valeria; De Felici, Massimo; Novelli, Giuseppe.

In: Frontiers in Bioscience, Vol. 13, No. 8, 2008, p. 2989-2999.

Research output: Contribution to journalArticle

Sangiuolo, F, Scaldaferri, ML, Filareto, A, Spitalieri, P, Guerra, L, Favia, M, Caroppo, R, Mango, R, Bruscia, E, Gruenert, DC, Casavola, V, De Felici, M & Novelli, G 2008, 'CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR)', Frontiers in Bioscience, vol. 13, no. 8, pp. 2989-2999. https://doi.org/10.2741/2904
Sangiuolo F, Scaldaferri ML, Filareto A, Spitalieri P, Guerra L, Favia M et al. CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR). Frontiers in Bioscience. 2008;13(8):2989-2999. https://doi.org/10.2741/2904
Sangiuolo, Federica ; Scaldaferri, Maria Lucia ; Filareto, Antonio ; Spitalieri, Paola ; Guerra, Lorenzo ; Favia, Maria ; Caroppo, Rosa ; Mango, Ruggiero ; Bruscia, Emanuela ; Gruenert, Dieter C. ; Casavola, Valeria ; De Felici, Massimo ; Novelli, Giuseppe. / CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR). In: Frontiers in Bioscience. 2008 ; Vol. 13, No. 8. pp. 2989-2999.
@article{19b6fc7971a34794ab6433e4be89f83e,
title = "CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR)",
abstract = "Different gene targeting approaches have been developed to modify endogenous genomic DNA in both human and mouse cells. Briefly, the process involves the targeting of a specific mutation in situ leading to the gene correction and the restoration of a normal gene function. Most of these protocols with therapeutic potential are oligonucleotide based, and rely on endogenous enzymatic pathways. One gene targeting approach, {"}Small Fragment Homologous Replacement (SFHR){"}, has been found to be effective in modifying genomic DNA. This approach uses small DNA fragments (SDF) to target specific genomic loci and induce sequence and subsequent phenotypic alterations. This study shows that SFHR can stably introduce a 3-bp deletion (deltaF508, the most frequent cystic fibrosis (CF) mutation) into the Cftr (CF Transmembrane Conductance Regulator) locus in the mouse embryonic stem (ES) cell genome. After transfection of deltaF508-SDF into murine ES cells, SFHR-mediated modification was evaluated at the molecular levels on DNA and mRNA obtained from transfected ES cells. About 12{\%} of transcript corresponding to deleted allele was detected, while 60{\%} of the electroporated cells completely last any measurable CFTR-dependent chloride efflux The data indicate that the SFHR technique can be used to effectively target and modify genomic sequences in ES cells. Once the SFHR-modified ES cells differentiate into different cell lineages they can be useful for elucidating tissue-specific gene function and for the development of transplantation-based cellular and therapeutic protocols.",
keywords = "CFTR, Embryonic stem cells, Homologous replacement, Real-time PCR, SFHR",
author = "Federica Sangiuolo and Scaldaferri, {Maria Lucia} and Antonio Filareto and Paola Spitalieri and Lorenzo Guerra and Maria Favia and Rosa Caroppo and Ruggiero Mango and Emanuela Bruscia and Gruenert, {Dieter C.} and Valeria Casavola and {De Felici}, Massimo and Giuseppe Novelli",
year = "2008",
doi = "10.2741/2904",
language = "English",
volume = "13",
pages = "2989--2999",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "8",

}

TY - JOUR

T1 - CFTR gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR)

AU - Sangiuolo, Federica

AU - Scaldaferri, Maria Lucia

AU - Filareto, Antonio

AU - Spitalieri, Paola

AU - Guerra, Lorenzo

AU - Favia, Maria

AU - Caroppo, Rosa

AU - Mango, Ruggiero

AU - Bruscia, Emanuela

AU - Gruenert, Dieter C.

AU - Casavola, Valeria

AU - De Felici, Massimo

AU - Novelli, Giuseppe

PY - 2008

Y1 - 2008

N2 - Different gene targeting approaches have been developed to modify endogenous genomic DNA in both human and mouse cells. Briefly, the process involves the targeting of a specific mutation in situ leading to the gene correction and the restoration of a normal gene function. Most of these protocols with therapeutic potential are oligonucleotide based, and rely on endogenous enzymatic pathways. One gene targeting approach, "Small Fragment Homologous Replacement (SFHR)", has been found to be effective in modifying genomic DNA. This approach uses small DNA fragments (SDF) to target specific genomic loci and induce sequence and subsequent phenotypic alterations. This study shows that SFHR can stably introduce a 3-bp deletion (deltaF508, the most frequent cystic fibrosis (CF) mutation) into the Cftr (CF Transmembrane Conductance Regulator) locus in the mouse embryonic stem (ES) cell genome. After transfection of deltaF508-SDF into murine ES cells, SFHR-mediated modification was evaluated at the molecular levels on DNA and mRNA obtained from transfected ES cells. About 12% of transcript corresponding to deleted allele was detected, while 60% of the electroporated cells completely last any measurable CFTR-dependent chloride efflux The data indicate that the SFHR technique can be used to effectively target and modify genomic sequences in ES cells. Once the SFHR-modified ES cells differentiate into different cell lineages they can be useful for elucidating tissue-specific gene function and for the development of transplantation-based cellular and therapeutic protocols.

AB - Different gene targeting approaches have been developed to modify endogenous genomic DNA in both human and mouse cells. Briefly, the process involves the targeting of a specific mutation in situ leading to the gene correction and the restoration of a normal gene function. Most of these protocols with therapeutic potential are oligonucleotide based, and rely on endogenous enzymatic pathways. One gene targeting approach, "Small Fragment Homologous Replacement (SFHR)", has been found to be effective in modifying genomic DNA. This approach uses small DNA fragments (SDF) to target specific genomic loci and induce sequence and subsequent phenotypic alterations. This study shows that SFHR can stably introduce a 3-bp deletion (deltaF508, the most frequent cystic fibrosis (CF) mutation) into the Cftr (CF Transmembrane Conductance Regulator) locus in the mouse embryonic stem (ES) cell genome. After transfection of deltaF508-SDF into murine ES cells, SFHR-mediated modification was evaluated at the molecular levels on DNA and mRNA obtained from transfected ES cells. About 12% of transcript corresponding to deleted allele was detected, while 60% of the electroporated cells completely last any measurable CFTR-dependent chloride efflux The data indicate that the SFHR technique can be used to effectively target and modify genomic sequences in ES cells. Once the SFHR-modified ES cells differentiate into different cell lineages they can be useful for elucidating tissue-specific gene function and for the development of transplantation-based cellular and therapeutic protocols.

KW - CFTR

KW - Embryonic stem cells

KW - Homologous replacement

KW - Real-time PCR

KW - SFHR

UR - http://www.scopus.com/inward/record.url?scp=38449096253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449096253&partnerID=8YFLogxK

U2 - 10.2741/2904

DO - 10.2741/2904

M3 - Article

C2 - 17981772

AN - SCOPUS:38449096253

VL - 13

SP - 2989

EP - 2999

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 8

ER -